Serum soluble urokinase plasminogen activator receptor and early stage of diabetic kidney disease in patients with type 2 diabetes

被引：0
|
作者：
Wang, Tao [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
961969
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease
    Hayek, Salim S.
    Landsittel, Douglas P.
    Wei, Changli
    Zeier, Martin
    Yu, Alan S. L.
    Torres, Vicente E.
    Roth, Sharin
    Pao, Christina S.
    Reiser, Jochen
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 30 (07): : 1305 - 1313
  • [32] Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension
    Bayrakci, Nergiz
    Ozkan, Gulsum
    Kara, Sonat Pinar
    Yilmaz, Ahsen
    Celikkol, Aliye
    TURKISH JOURNAL OF NEPHROLOGY, 2024, 33 (02): : 173 - 178
  • [33] SERUM UROKINASE-TYPE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE PANCREATITIS
    Can, Ummugulsum
    Baser, Salih
    Yerlikaya, Fatma Humeyra
    Karasoy, Deniz
    NOBEL MEDICUS, 2021, 17 (01): : 48 - 53
  • [34] Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia
    Genc, Abdullah
    Kalelioglu, Tevfik
    Karamustafalioglu, Nesrin
    Tasdemir, Akif
    Genc, Esra Sena
    Akkus, Mustafa
    Emul, Murat
    PSYCHIATRY RESEARCH, 2016, 236 : 179 - 181
  • [35] Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma
    Chounta, Athina
    Ellinas, Christofer
    Tzanetakou, Vassiliki
    Pliarhopoulou, Fani
    Mplani, Virginia
    Oikonomou, Angelos
    Leventogiannis, Kostantinos
    Giamarellos-Bourboulis, Evangelos J.
    LIVER INTERNATIONAL, 2015, 35 (02) : 601 - 607
  • [36] Assessment of Serum Levels of Soluble Urokinase Plasminogen Activator Receptor (suPAR) in Patients with Periodontitis and Atheroscletotic Cardiovascular Disease
    Hamad, Safa Ali
    Mahmood, Maha Shukri
    JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (02): : 719 - 723
  • [37] Serum Soluble Urokinase-type Plasminogen Activator Receptor is Associated With the Prevalence of Atrial Fibrillation
    Miyamura, Masatoshi
    Ichihara, Noboru
    Yamauchi, Yohei
    Fujimura, Yuki
    Maeda, Daichi
    Fujisaka, Tomohiro
    Fujita, Shu-ichi
    Morita, Hideaki
    Takeda, Yoshihiro
    Ito, Takahide
    Sohmiya, Koichi
    Hoshiga, Masaaki
    Ishizaka, Nobukazu
    CIRCULATION, 2017, 136
  • [38] Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
    Renáta M. Böcskei
    Béla Benczúr
    György Losonczy
    Miklós Illyés
    Attila Cziráki
    Veronika Müller
    Anikó Bohács
    András Bikov
    Lung, 2019, 197 : 189 - 197
  • [39] Soluble Urokinase-Type Plasminogen Activator Receptor and Arterial Stiffness in Patients with COPD
    Bocskei, Renata M.
    Benczur, Bela
    Losonczy, Gyorgy
    Illyes, Miklos
    Cziraki, Attila
    Mueller, Veronika
    Bohacs, Aniko
    Bikov, Andras
    LUNG, 2019, 197 (02) : 189 - 197
  • [40] Plasma Soluble Urokinase-type Plasminogen Activator Receptor (suPAR) as an Early Indicator of Sickle Cell Disease-Associated Chronic Kidney Disease
    Afangbedji, Nowah
    Taye, Ammanuel
    Smith, Nathan
    Niu, Xiomei
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    FASEB JOURNAL, 2019, 33
12345